Cochrane Reviews - by sub-topics 'Metabolic and Endocrine Disorders'

The Cochrane Collaboration
Cochrane Reviews

Advanced search

Explore

Other languages

search & browse

|

|

full list of all reviews

|

by country of author

|

Audio summaries | Evidence Aid summaries | Cochrane Methodology abstracts

by sub-topics:

For complete list (no sub-topics), click here - Browse by sub-topic (Review Group)

Can't find a review topic below covering your question or interest? Suggest one:

*

Consider types of interventions, problems or issues, and who might be affected. Example: Effects of surgical sphenoidal sinusitis treatments in young people.

To hide this form click here

*

= required

*

Why are you suggesting this topic?:

Example:
"This affects millions of people. Your search doesn't turn up any mention of it."

*

Name:

*

Role:

Organization:

Example:
University Hospital Freiburg

*

Country:

*

Email:

Your email address will be used to contact you, should our staff wish to followup on your suggestions. It will NOT be shared beyond this purpose.

Other contact details

More about privacy

Metabolic and Endocrine Disorders Group (88)

Diabetes mellitus and Related Disorders (54)

Diabetes mellitus (49)

Diabetes mellitus - General (11)

'Human' insulin versus animal insulin in people with diabetes mellitus

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria (withdrawn)

Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus (withdrawn)

Inhaled insulin in diabetes mellitus (withdrawn)

Long-term non-pharmacological weight loss interventions for adults with prediabetes

Mobile phone messaging - a telemedicine for people with diabetes mellitus (protocol stage)

Psychological interventions for improving glycaemic control in patients with diabetes mellitus (protocol stage) (withdrawn)

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

Specialist nurses in diabetes mellitus

Systems for routine surveillance for people with diabetes mellitus

Type 1 Diabetes mellitus (formerly: insulin-dependent) (5)

Antithyroid drug regimen for treating Graves' hyperthyroidism

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus (protocol stage)

Glargine versus other basal insulins (NPH, Lente, or Ultralente) for the treatment of type 1 diabetes mellitus (protocol stage)

Intranasal insulin for type 1 diabetes mellitus (protocol stage)

Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus

Type 2 Diabetes mellitus (formerly: non-insulin-dependent) (30)

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Chinese herbal medicines for type 2 diabetes mellitus

Dietary advice for the prevention of type 2 diabetes mellitus in adults

Dietary advice for treatment of type 2 diabetes mellitus in adults

Exercise for type 2 diabetes mellitus

Exercise or exercise and diet for preventing type 2 diabetes mellitus

Extended-release metformin versus immediate-release metformin for type 2 diabetes mellitus (protocol stage)

Family based interventions to improve outcomes in patients with type 2 diabetes mellitus (protocol stage)

Glucagon-like peptide analogues for type 2 diabetes mellitus (protocol stage)

Group based training for self-management strategies in people with type 2 diabetes mellitus

Individual patient education for people with type 2 diabetes mellitus (protocol stage)

Initiating and maintaining physical activity for type 2 diabetes mellitus (protocol stage) (withdrawn)

Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus

Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus

Long-acting insulin analogue versus another long-acting insulin analogue for type 2 diabetes mellitus (protocol stage)

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus

Meglitinide analogues for type 2 diabetes mellitus

Metformin monotherapy for type 2 diabetes mellitus

Nutritional supplementation for glycaemic control in type 2 diabetes mellitus (protocol stage)

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

Pioglitazone for type 2 diabetes mellitus

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Rosiglitazone for type 2 diabetes mellitus

Screening for type 2 diabetes mellitus (protocol stage)

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin

Sulfonylureas for treating type 2 diabetes mellitus (protocol stage) (withdrawn)

Whole grain foods for the prevention of type 2 diabetes mellitus

Zinc supplementation for the prevention of type 2 diabetes mellitus

Other types of Diabetes mellitus (1)

Latent autoimmune diabetes in adults (LADA) (1)

Interventions for latent autoimmune diabetes (LADA) in adults

Lipoatrophic Diabets mellitus (0)

Diabetic Coma (0)

Diabetic Ketoacidosis (0)

Obesity in Diabetes (2)

Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

Pregnancy in Diabetes (see also Pregnancy and Childbirth Group) (0)

Gestational Diabetes (0)

Fetal Macrosomia (0)

Diabetes Complications (5)

Diabetic Angiopathies (see also Peripheral Vascular Disease Group, Hypertension Group, and Heart Group) (2)

Acetylsalicylic acid (Aspirin) for primary prevention of cardiovascular disease in type 2 diabetes mellitus (protocol stage)

Pharmacological interventions for preventing cardiovascular complications in people with type 2 diabetes mellitus (protocol stage)

Diabetic Retinopathy (see also Eyes and Vision Group) (0)

Diabetic Nephropathies (see also Renal Group) (2)

Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria (withdrawn)

Protein restriction for diabetic renal disease

Diabetic Neuropathies (see also Neuromuscular Disorders Group, and Pain, Palliative Supportive Care Group) (0)

Diabetic Foot (see also Wounds Group) (0)

Other neuropathies (0)

Erectile dysfunction (1)

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

Related Disorders (0)

Glucose Intolerance (0)

Glycosuria (0)

Hyperglycaemia (0)

Hypoglycaemia (0)

Hyperinsulinaemia (0)

Hyperinsulinism (0)

Other Metabolic and Nutritional Disorders (20)

Metabolic Disorders (0)

Digestive System (0)

Achlorhydria (0)

Malabsorption Syndromes (0)

Protein-Losing Enteropathies (0)

Water, Electrolytes, Acid-Base (0)

Water-Electrolyte Imbalance (0)

Acid-Base Imbalance (0)

Diabetes Insipidus (0)

Vitamins, Minerals (0)

Calcium Metabolism Disorders (0)

Iron Metabolism Disorders (0)

Phosphorus Metabolism Disorders (0)

Hypervitaminoses (0)

Lipids (0)

Hyperlipidaemia (0)

Nutritional Disorders (20)

Deficiency Diseases (e.g. avitaminoses. mineral deficiency, protein deficiency etc.) (6)

Interventions for the prevention of nutritional rickets in term born children

Iodine supplementation for preventing iodine deficiency disorders in children

Iron supplementation for iron deficiency anemia in children (protocol stage)

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency

Parenteral calcium for intensive care unit patients

Protein and energy supplementation in elderly people at risk from malnutrition

Obesity (14)

Advice on low-fat diets for obesity (withdrawn)

Chinese herbal medicines for weight loss (protocol stage)

Chitosan for overweight or obesity

Exercise for overweight or obesity

Intragastric balloon for obesity

Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus

Long-term pharmacotherapy for obesity and overweight

Low glycaemic index or low glycaemic load diets for overweight and obesity

Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

Psychological interventions for overweight or obesity

Rimonabant for overweight or obesity

Surgery for morbid obesity

Weight reduction for primary prevention of stroke in adults with overweight or obesity

Weight reduction for reducing mortality in obesity and overweight (protocol stage)

Other Endocrine Disorders (12)

Non-malignant (9)

Adrenal Gland Diseases (0)

Pituitary Diseases (1)

Recombinant growth hormone for idiopathic short stature in children and adolescents

Thymus Diseases (0)

Thyroid Diseases (8)

Adjunctive antithyroid drugs in radioiodine therapy for hyperthyroidism (protocol stage)

Chinese herbal medicines for hyperthyroidism

Iodine supplementation for preventing iodine deficiency disorders in children

Iodised salt for preventing iodine deficiency disorders

Pharmacotherapy for thyroid nodules (protocol stage)

Radioiodine treatment for pediactric Graves' disease

Thyroid hormone replacement for subclinical hypothyroidism

Thyroxine monotherapy versus thyroxine-triiodothyronine combination therapy for hypothyroidism (protocol stage)

Parathyroid Diseases (0)

Hyperprolactinaemia (0)

Dwarfism (0)

Gonadal Disorders (0)

Autoimmune Polyendocrinopathies (0)

Malignant (1)

Adrenal Neoplasms (0)

Thyroid Neoplasms (1)

Adjunctive antithyroid drugs in radioiodine therapy for hyperthyroidism (protocol stage)

Parathyroid Neoplasms (0)

Pituitary Neoplasms (0)

Thymus Neoplasms (0)

Multiple Endocrine Neoplasia (0)

Neoplastic Endocrine-Like Symptoms (0)

Genetic Disorders (2)

Recombinant growth hormone for children and adolescents with Turner syndrome

Recombinant growth hormone in Prader-Willi Syndrome (protocol stage)

Non-classified Metabolic or Endocrine Conditions (2)

Growth hormone treatment for short stature in children with fetal growth restriction (protocol stage)

Recombinant growth hormone for idiopathic short stature in children and adolescents

top of page | contact us | about this site | disclaimer | privacy